Shares in CVS (CVSG:AIM) rose after the Competition and Markets Authority (CMA) finally concluded its veterinary services market investigation. The competition watchdog launched its probe to address weak competition and soaring prices in the UK’s £6.7 billion-plus vets sector. There was relief among CVS investors, and shareholders in Pets at Home (PETS), as the CMA’s … Continue reading CVS rises as CMA decision brings certainty